HIV Infection and Carcinoma of the Conjunctiva - Mvungi, Nanzoke Theobald
23,99 €
inkl. MwSt.

Versandfertig in 6-10 Tagen
payback
12 °P sammeln
  • Broschiertes Buch

Incidence of conjunctiva carcinoma in developed countries has been increasing despite of the introduction of anti-retroviral therapy, Conjunctiva carcinoma as one of the AIDS defining disease is a significant contributor of top ten cancers at ORCI (ORCI cancer trend). Peak incidence occurs in the economically and most sexually active age group. Enucleation, radiotherapy and ARVs is the major treatment modality at ORCI. Studies on the association of between HIV infection and carcinoma of the conjunctiva are available in developed and developing countries but this information is scant in…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Incidence of conjunctiva carcinoma in developed countries has been increasing despite of the introduction of anti-retroviral therapy, Conjunctiva carcinoma as one of the AIDS defining disease is a significant contributor of top ten cancers at ORCI (ORCI cancer trend). Peak incidence occurs in the economically and most sexually active age group. Enucleation, radiotherapy and ARVs is the major treatment modality at ORCI. Studies on the association of between HIV infection and carcinoma of the conjunctiva are available in developed and developing countries but this information is scant in Tanzania. The association of HIV infection and conjunctiva carcinoma is high (significant) in our settings but has not been systematically documented. This study address these gaps.
Autorenporträt
Dr. Nanzoke Mvungi ist klinische Onkologin am Ocean Road Cancer Institute in Tansania. Sie hat einen Doktortitel in Medizin (2008) und einen Master-Abschluss in klinischer Onkologie (2015) von der Muhimbili University of Health and Allied Sciences, Tansania.